Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Bone health and multiple sclerosis.
Chiasmal optic neuritis in a 4-year-old girl: a case report and review of the literature.
Development of a selective S1P1 receptor agonist, Syl930, as a potential therapeutic agent for autoimmune encephalitis.
Glutathione in multiple sclerosis: More than just an antioxidant?
Higher burden of migraine compared to other neurological conditions: results from a cross-sectional study.
Increased immunopotency of monocyte derived dendritic cells from patients with optic neuritis is inhibited in vitro by simvastatin.
Oral fingolimod reduces glutamate-mediated intracortical excitability in relapsing-remitting multiple sclerosis.
Obesity in autoimmune diseases: Not a passive bystander.
Alemtuzumab for relapsing-remitting multiple sclerosis.
Modulation of a pore in the capsid of JC polyomavirus reduces infectivity and prevents exposure of the minor capsid proteins.
Infectious mononucleosis.
Predictors of disability worsening in clinically isolated syndrome.
Exposure to anaesthetic agents does not affect multiple sclerosis risk.
Nanowire-mediated delivery enables functional interrogation of primary immune cells: application to the analysis of chronic lymphocytic leukemia.
Gene Therapy of Multiple Sclerosis Using Interferon β -Secreting Human Bone Marrow Mesenchymal Stem Cells.
Dengue fever in patients with multiple sclerosis taking fingolimod or natalizumab.
Correlation between spasticity and quality of life in patients with multiple sclerosis: the CANDLE study.
Clinical experiences with cannabinoids in spasticity management in multiple sclerosis.
Distribution Patterns of 18F-Labelled Fluoromethylcholine in Normal Structures and Tumors of the Head: A PET/MRI Evaluation.
Serum levels of LIGHT in MS.
The onset location of neuromyelitis optica spectrum disorder predicts the location of subsequent relapses.
Tau protein concentrations in the cerebrospinal fluid of children with acute disseminated encephalomyelitis.
Signalling Pathways that Inhibit the Capacity of Precursor Cells for Myelin Repair.
The role of IFNβ in the treatment of MSand EAE - In the perspective of inflammasomes.
Multiple sclerosis: Linking disability and spinal cord imaging outcomes in MS.
Pages
« first
‹ previous
…
303
304
305
306
307
308
309
310
311
…
next ›
last »